|
Seminar Presenters B. Nicolas Bloch, MD
David Bostwick, MD, MBA
|
Shopping Cart
B. Nicolas Bloch, MD, is Assistant Professor of Radiology at the Boston University School of Medicine, Boston, MA. He received his medical doctorate from the University of Vienna in Austria in June of 1997. His postdoctoral training included internships at the University of Tel Aviv, Medical University of Vienna, and Beth Israel Hospital in Boston, an affiliate of Harvard Medical School. He has studied the use of Dynamic Contrast Enhanced (DCE) MRI of the prostate and breast and has published extensively in this area of novel tissue imaging.
David Bostwick, MD, MBA, is the Chief Executive Officer/Chief Medical Officer of Bostwick Laboratories in Richmond, VA. Dr. Bostwick also serves as a Clinical Professor of Pathology at the University of Virginia in Charlottesville, VA. and is a Consultant to the Oncology Division of the NIH in Bethesda, MD. Previous appointments have included serving as Pathologist-in-Chief, Urology of Virginia, Norfolk, VA, Pathologist-in-Chief, Virginia Urology Center, Richmond VA, and Consultant and Professor of Pathology and Urology, Mayo Clinic and Mayo Medical School, Rochester, MN. Dr. Bostwick received his medical doctorate from the University of Maryland in 1979 and had Research Fellowships at Stanford University Medical Center. He received his MBA degree from Loyola College of Maryland in 1991. Dr. Bostwick is internationally recognized as a premier prostate pathologist and has published extensively.
Michael J. Dattoli, MD, is the Director of the Dattoli Cancer Center & Brachytherapy Research Institute in Sarasota, FL. He received hismedical doctorate from the Mt. Sinai School of Medicine where he had
Ernest J. Feleppa, PhD, is the Research Director of the Frederic L. Lizzi Center for Biomedical Engineering at the Riverside Research Institute, a not-for-profit research organization based in New York City. He received his undergraduate degree in physics at Cornell and his doctorate in biophysics from Columbia University. His research work has been largely devoted to disease detection, diagnosis and monitoring using non-invasive ultrasound methodology. Dr. Feleppa is an Adjunct Professor at Columbia University, New York Medical College and Drexel University.
Martin Haas, PhD, is an Adjunct Professor in the Biology Section of the Cancer Center of the University of California, San Diego. He received his doctorate in biophysics from the University of California, Berkeley, after receiving his Bachelor of Science in Electrical Engineering from the Technion, Israel Institute of Technology, in Israel. He has had experience in the laboratories of the Weizmann Institute in Israel and then as a Professor at the University of California, San Diego. Dr. Haas has been studying the role stem cells may play in prostate cancer, especially in relation to the development of hormonal resistance.
Barnett S. Kramer, MD, MPH, is Associate Director for Disease Prevention and Director of the Office of Medical Applications of Research in the Office of Disease Prevention at the National Institutes of Health (NIH). He also is a Clinical Professor in the Department of Medicine of the Uniformed Services University of the Health Sciences in Bethesda, MD. Dr. Kramer received his medical doctorate from the University of Maryland Medical School and his master’s degree in public health from Johns Hopkins University School of Hygiene and Public Health. Dr. Kramer has had extensive experience in cancer treatment studies, primary prevention studies, and clinical screening studies for lung, ovarian, prostate and other cancers. He is the Medical Officer responsible for the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial, one of the recent trials that challenged the usefulness of PSA screening for prostate cancer.
Kendall Nettles, PhD, is an Associate Professor in the Department of Cancer Biology at Scripps Florida. He received his undergraduate degree from Colgate University in 1990 and received his doctorate in cancer biology from the University of Chicago in 2003. Dr. Nettles did post-graduate work in Structural Genomics at the Argonne National Laboratories. At Scripps, Dr. Nettles conducts active research on the subject of hormonal effects on cancer cells. He is currently investigating a potential drug that would be applicable to prostate cancer as well as other diseases.
Sanjay Razdan, MD, MCh, is the Director of the Urology Center of Excellence of South Florida and is the Chairman, Department of Surgery, at the Jackson South Hospital in Miami, Florida. He is also the Director of The International Robotic Prostatectomy Institute at the same hospital. Dr. Razdan received his medical doctorate from the G.S.V.M Medical School in India in 1985. He is the recipient of awards from numerous prestigious institutions including the American Medical Association, Boston University Medical Center, The Society of Laparoendoscopic Surgeons and others. Dr. Razdan has published many articles on laparoscopic and robotic surgery. He frequently performs surgery with the DaVinci robot- assisted system.
Oliver Sartor, MD, is Professor of Medicine and Urology at the Tulane Medical School in New Orleans, LA. Prior to this engagement, he was an Associate Professor of Medicine at the Dana-Farber Cancer Institute of the Harvard Medical School in Boston, MA. Dr. Sartor received his medical doctorate from Tulane University in 1982. He interned at Tulane Medical and was a Fellow in Medical Oncology at the National Cancer Institute in Bethesda. He has published extensively in the field of prostate cancer medicine and participated in drafting the American Urological Association’s position on PSA screening.
Johannes Vieweg, MD, is the Professor and Founding Chairman of the Department of Urology at the University of Florida in Gainesville, FL. He also holds the Huizenga Eminent Endowed Chair in Urologic Oncology at UF. He received his medical doctorate from the University of Regensburg in Germany. Upon relocating to the United States, he did three years of postdoctoral training at Memorial Sloan Kettering Hospital in New York City. Dr. Vieweg was a member of the faculty of Duke University in Durham, NC, for nine years prior to joining the staff at the University of Florida in Gainesville where he led the creation and growth of the Urologic Oncology Division of the UF Medical School. He is currently leading a program to build a collaborative network of programs across the State of Florida to couple advances in biomedical research with improvement of prostate cancer care, research and education. MyHIR.org, Design by 1905 Graphics, Inc. | Web Hosting by SpecSys Solutions
|
Seminar Presenters B. Nicolas Bloch, MD
David Bostwick, MD, MBA
|